Trials
3 known investors
Find your way into Trials
Sign up to see every warm intro you have to Trials
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Trials team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Trials.ai builds agentic AI technology for clinical trial design, digitizing and automating study creation while offering AI-powered recommendations on endpoints, eligibility criteria, schedules, and patient populations. Its products, powered by a clinical study ontology and data graph, serve life sciences and clinical development teams.
Founders & leadership
Investors · 3
Amplify.LAlisted by Amplify.LALos Angeles · $500K – $5M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Trials do?
- Trials.ai builds agentic AI technology for clinical trial design, digitizing and automating study creation while offering AI-powered recommendations on endpoints, eligibility criteria, schedules, and patient populations. Its products, powered by a clinical study ontology and data graph, serve life sciences and clinical development teams.
- Who founded Trials?
- Trials was founded by Kim Walpole.
- Who are Trials's investors?
- Trials's investors include Amplify.LA, Gaingels, Harmonix Fund.
__Twitter.png)